GGrantIndex
Sort

40,608 grants matching prostate cancer

Novel Biguanides to Treat Type 2 Diabetes

$651,885
Ken W Batchelor · Novatarg, Inc. · R44 · FY2015 · DK

Biomarker Approaches to Individualizing Systemic Therapy for High Risk Prostate Cancer

$651,833
Felix Yi-Chung Feng · University Of California, San Francisco · R01 · FY2020 · CA

Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients

$651,831
Daniel B Vigneron · University Of California, San Francisco · U01 · FY2020 · CA

PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization

$651,717
James Peter Basilion · Case Western Reserve University · R01 · FY2023 · CA

A dyadic exercise approach to prevent declines in physical and mental health in couples during radiation treatment for cancer: a hybrid type I efficacy-implementation trial

$651,714
Kerri M Winters-Stone · Oregon Health & Science University · R01 · FY2025 · CA

SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)

$651,680
Jose M. Garcia · Seattle Inst For Biomedical/Clinical Res · R01 · FY2024 · CA

Advanced PET-CT Directed Post-Prostatectomy Radiotherapy to Enhance Prostate Cancer Outcomes

$651,443
Ashesh Jani · Emory University · R01 · FY2021 · CA

Nuclear Factor-kappaB in Ovarian Cancer

$651,396
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Evaluation of Transperineal Biopsy under Local Anesthesia, a Novel approach to Decrease Post-Biopsy Infections and Improve Cancer Detection

$651,354
Jim Hu · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR)

$651,340
Ian M Thompson · University Of Texas Hlth Science Center · U01 · FY2013 · CA

Role of Novel Cytokine Secretoglobin (SCGB) 3A2 in Lung

$651,304
Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial

$651,255
Adriana Coletta · University Of Utah · R01 · FY2024 · CA

Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers

$651,215
William C Hahn · Broad Institute, Inc. · R01 · FY2023 · CA

MELT: Modulation of PSMA Expression for Lutetium Therapy

$651,214
Thomas Hope · University Of California, San Francisco · R01 · FY2021 · CA

Molecular regulation and expression of Trop-2 in advanced prostate cancer: Identifying optimal therapeutic niches

$651,191
Joshua Michael Lang · University Of Wisconsin-Madison · R01 · FY2025 · CA

Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data

$651,010
Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2023 · CA

Personal Patient Profile-Prostate: Testing and Implementation in Health Networks

$650,614
Donna L. Berry · Dana-Farber Cancer Inst · R01 · FY2014 · NR

Mechanism of epigenetic activation during disease progression

$650,607
David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Identification of epigenetic drivers of advanced prostate cancer

$650,607
David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction

$650,522
Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA

Robot-assisted catheter placement with novel shape-sensing stylet to facilitate adaptive image guided pelvic brachytherapy

$650,503
Junichi Tokuda · Brigham And Women'S Hospital · R01 · FY2024 · EB

Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials

$650,466
Jeffrey Schlom · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Biochemical and cellular analysis of regulatory T cells reactive to a natural self antigen

$650,415
Erin June Adams · University Of Chicago · R01 · FY2018 · AI

Biochemical and cellular analysis of regulatory T cells reactive to a natural self antigen

$650,415
Erin June Adams · University Of Chicago · R01 · FY2020 · AI

Biochemical and cellular analysis of regulatory T cells reactive to a natural self antigen

$650,415
Erin June Adams · University Of Chicago · R01 · FY2019 · AI